Teladoc Stock News

I did not invest in teledoc when it was reasonably priced , however, now might be an opportunity the only issue i have is that you have no ability to create a relationship with one doctor. you just get anyone, and for me thats a big problem was the spike in price partly linked with []

Berman Capital Advisors LLC boosted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 221.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 459 shares of the health services providers stock after acquiring an additional 316 shares during the quarter. Berman Capital []

Teladoc Health (NYSE:TDOC) had its price objective lowered by Stephens from $140.00 to $135.00 in a research note issued to investors on Friday morning, Price Targets.com reports. The brokerage currently has an equal weight rating on the health services providers stock. Several other equities research analysts also recently commented on TDOC. Oppenheimer reduced their price []

Teladoc Health (NYSE:TDOC) had its price target lowered by Credit Suisse Group from $208.00 to $207.00 in a report released on Friday, Price Targets.com reports. Credit Suisse Group currently has an outperform rating on the health services providers stock. A number of other research firms also recently weighed in on TDOC. Canaccord Genuity lowered their []

Metropolitan Life Insurance Co NY increased its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 43,228.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,033 shares of the health services providers stock after purchasing an additional 3,026 shares during the quarter. Metropolitan []

Teladoc Health (NYSE:TDOC) had its price objective decreased by equities research analysts at SVB Leerink from $205.00 to $193.00 in a research note issued on Friday, PriceTargets.com reports. The brokerage presently has an outperform rating on the health services providers stock. SVB Leerinks price target would indicate a potential upside of 64.97% from the stocks []

Teladoc Health, Inc. (NYSE:TDOC) shares reached a new 52-week low on Friday after Credit Suisse Group lowered their price target on the stock from $208.00 to $207.00. Credit Suisse Group currently has an outperform rating on the stock. Teladoc Health traded as low as $120.54 and last traded at $120.65, with a volume of 160201 []

Wedbush Securities Inc. lowered its position in Teladoc Health, Inc. (NYSE:TDOC) by 9.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,744 shares of the health services providers stock after selling 1,113 shares during the period. Wedbush Securities []

Teladoc Health (NYSE:TDOC) had its target price cut by stock analysts at Citigroup from $190.00 to $175.00 in a research report issued on Friday, The Fly reports. The brokerage presently has a buy rating on the health services providers stock. Citigroups price target suggests a potential upside of 41.13% from the companys current price. Other []

Teladoc Health, Inc. (NYSE:TDOC) fell 7.7% on Thursday . The company traded as low as $122.81 and last traded at $124.43. 140,648 shares traded hands during mid-day trading, a decline of 95% from the average session volume of 2,945,231 shares. The stock had previously closed at $134.85. A number of research analysts recently commented on []